Belle-Gradient-2-1 1

Hero-Image-extended-left-e1709294343740-1440x810

A simple blood test to aid early detection of cancer in dogs.

Veterinarians Pet Parents

Disease

Earlier detection can improve outcomes.

Cancer is the most common cause of death in dogs over the age of 2 years in the US.

Earlier cancer detection can improve outcomes. It can also improve the quality of life of the dog and its owner.

Yet, as of today, there are few single assay cancer blood tests on the veterinary market. Currently, dogs are usually diagnosed when they are unwell or there is a suspicion of cancer. Even then, dogs suspected of having cancer are required to undergo a variety of diagnostic tests that may be expensive, time consuming, and painful for the animal.

We hope to change this with the introduction of the Nu.Q^® Vet Cancer Test.

0 %

It is estimated that 50% of all dogs over the age of 10 will develop cancer in their lifetimes.

0 m

There are an estimated 6 million pet dogs diagnosed with cancer each year.

Why is testing so important?

Screening refers to tests performed on healthy, asymptomatic patients who have disease but do not yet have symptoms.

Screening is the first step in catching disease early, and allows for better treatment outcomes. As cancer develops in the body, screening also plays an important part in identifying it sooner before it has spread or metastasized.

The Nu.Q^® Vet Cancer Test turns ‘early diagnosis’ from a daunting task to a meaningful conversation between vets and pet parents.

sebastian-coman-travel-JgKfmp9uq9w-unsplash

testimonial

This technology has become an indispensable part of our diagnostic protocols, allowing us to provide a higher standard of care and peace of mind to the families who trust us with their pets.

Dr. Oscar Paez Castro
Veterinarian and founder, Coral Way Animal Clinic, Miami, Florida

Our Solution

Introducing Nu.Q^® Vet Cancer Test.

Early detection improves outcomes

The Nu Q^® Vet Cancer Test was developed with the goal of providing an accessible and affordable screening test to aid in early detection.

This test can be easily integrated into preventive care programs and used alongside other routine bloodwork during regular wellness visits.

It’s a simple, easy to use screening blood test recommended for older dogs (7 years and older) and those breeds at increased risk of developing cancer in their lifetimes (from 4 years).

The Nu.Q^® Vet Cancer Test is now available in the United States, Europe, Australia and Asia.

Any questions? Read our FAQs

Veterinarian Stroking Dog Close Up

Learn about the Nu.Q® Vet Cancer Test

Veterinarians

The Nu.Q^® Vet Cancer Test is an affordable, accessible, easy-to-use screening test to aid in early canine cancer detection.

Learn more here.

Pet Parents

Earlier detection can improve outcomes. Find out more about the Nu.Q^® Vet Cancer Test.

A simple, easy to use screening blood test to be used by your veterinarian as part of your dog’s wellness check.

When Benjamin, a nine-year-old Labrador, showed signs of possible metastasis after treatment for hemangiosarcoma, the Nu.Q^® Vet Cancer Test confirmed a high-risk result, helping guide timely follow-up treatment. Although Ben later succumbed to metastatic disease, the extra months with him meant everything to his family.

Determined to stay proactive, Ben’s owners had their younger Lab, Boomer, tested. He was given a clean bill of health, including a low-risk Nu.Q^® score, and now gets tested every six months as part of his routine wellness care. Their newest pup, Baxter, will also begin regular Nu.Q^® screening when he turns four.

Keep reading Ben, Boomer, and Baxter’s story to learn how the Nu.Q^® Vet Cancer Test supports early detection, informed decisions, and peace of mind for pet families.

Read full case study

During a routine check-up, Belle, a seemingly healthy Golden Retriever, underwent the Nu.Q^® Vet Cancer Test. The results revealed elevated nucleosome levels, an early warning sign of cancer. Thanks to this early detection, Belle was quickly diagnosed with lymphoma and began treatment without delay.

Belle’s case highlights the power of the Nu.Q^® Vet Cancer Test to detect hidden cancers early, even in dogs with no symptoms, using just a simple blood draw.

Keep reading Belle’s case study to see how Nu.Q^® helped change the course of her care and why early detection matters.

Read full case study

Otis, a 12‑year‑old neutered male Catahoula mix, seemed healthy during a routine wellness exam—normal vitals, only mild dental tartar and a low-grade heart murmur. With no concerning symptoms, his vet still included the Nu.Q^® Vet Cancer Test in his bloodwork. The result came back in the high-risk (orange) zone, prompting a more thorough diagnostic work-up. Imaging and histopathology confirmed occult metastatic hemangiosarcoma—only detected because of the early warning from Nu.Q^®.

Read full case study

Charlie, an 8-year-old Labrador, was initially diagnosed with intermediate to large cell B-cell lymphoma after presenting with sudden blindness and uveitis. After successful treatment with CHOP chemotherapy, his routine rechecks included the Nu.Q^® Vet Cancer Test alongside standard labs.

At a follow-up with no major clinical symptoms, Charlie’s Nu.Q^® test returned a high-risk score, prompting immediate imaging. An abdominal ultrasound revealed a small splenic nodule, and fine-needle aspiration confirmed a recurrence of lymphoma. Thanks to the early alert from Nu.Q^®, treatment was restarted right away.

Keep reading Charlie’s case study to see how Nu.Q^® helped detect cancer before clinical signs returned—and how it supports proactive care and better outcomes for at-risk breeds

Read full case study

Product Resources

Brochures & Clinical Papers

Nu.Q® Vet White Paper: Detecting cancer early to give dogs a…

Nu.Q^® Vet Cancer Test Product Brochure (US)

Media & Downloads

Pet Parents Brochure – The value of canine cancer scre…

Media & Downloads

Introducing the Nu.Q^® Vet Cancer Test

Nu.Q^® Vet Cancer Test animation

Webinar series: How to use Nu.Q^® Vet Cancer Test

Evaluation of plasma nucleosome concentrations in dogs

Poster & Publications

Volition & Fujifilm Vet Systems Launch Nu.Q® Vet Cancer…

Utility of Monitoring H3.1 Plasma Concentrations as a Surrog…

Poster & Publications

Highlights from WVC 2024